Compare Johnson Controls International PLC (JCI) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson Controls International PLC vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Johnson Controls International PLC trades at $155.13 (market cap $93.28B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.37 (market cap $2.27B). The key difference: Johnson Controls International PLC is far larger — about 41.1× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Johnson Controls International PLC pays a 1.04% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| JCI | SLS | |
|---|---|---|
Market Cap | $93.28B | $2.27B |
Volume | 2,786,476 | 4,179,659 |
Sector | Basic Materials | Health |
52-Week High | $158.76 | $15.46 |
52-Week Low | $105.55 | $1.39 |
Typical Hold Time | 65 Days | — |
Enterprise Value | $102.12B | $2.14B |
Dividend Yield | 1.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson Controls International (JCI) trades at $155.93, down 1.78% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with an EPS of $1.42, and raised its full-year 2026 guidance. Revenue for 2025 was $23.60B, with net income surging to $3.29B, reflecting a robust profit margin of 13.94%. Analyst sentiment is positive, with a consensus price target of $172.50 and no sell ratings among 45 analysts.
The outlook for JCI is favorable, driven by strong demand in data-center and mission-critical thermal management systems, as highlighted in recent earnings. Investment opportunities include potential upside to the consensus target and consistent dividend payments. Key risks involve elevated valuation multiples, such as a P/E of 43.92, and macroeconomic sensitivity impacting industrial demand.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
